SCHEMBL6049182

SCHEMBL6049182

CSc1ccc(Oc2ccc(S(N)(=O)=O)cc2C2CCCN2C=O)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SLC6A4 P31645 9/20 0.49
▸ CA2 P00918 3/20 0.35
▸ CA1 P00915 2/20 0.35
▸ DRD2 P14416 2/20 0.35
▸ DRD1 P21728 2/20 0.35
▸ DRD4 P21917 2/20 0.35
▸ DRD3 P35462 2/20 0.35
▸ CA9 Q16790 2/20 0.35
▸ CYP1A2 P05177 2/20 0.35
▸ CYP2D6 P10635 2/20 0.35
▸ TSHR P16473 2/20 0.35
▸ CA12 O43570 1/20 0.35
▸ CA3 P07451 1/20 0.35
▸ ADRA2A P08913 1/20 0.35
▸ MAPT P10636 1/20 0.35
▸ PTGS1 P23219 1/20 0.35
▸ CA6 P23280 1/20 0.35
▸ CA5A P35218 1/20 0.35
▸ CA7 P43166 1/20 0.35
▸ BLM P54132 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL6049215 0.86 SLC6A4 (0.51) SLC6A4CA2CA1DRD2DRD1
SCHEMBL6049186 0.76 SLC6A4 (0.53) SLC6A4CA2CA1CA9TSHR
Hydrochloric Acid SCHEMBL6049202 0.75 SLC6A4 (0.52) SLC6A4CA2CA1CA9TSHR
Hydrochloric Acid SCHEMBL6049178 0.74 SLC6A4 (0.53) SLC6A4TSHRMAPTLMNASLC6A3
Uk-390957 SCHEMBL931652 0.66 SLC6A4 (1.00) SLC6A4SOS1SLC6A3SLC6A2
SCHEMBL15080486 0.66 SLC6A4 (0.72) SLC6A4SLC6A3HRH3SLC6A2
SCHEMBL23036750 0.65 ALDH1A1 (0.48) CA2CA1CYP1A2MAPT
SCHEMBL21491372 0.65 ALDH1A1 (0.48) CA2CA1CYP1A2MAPT
SCHEMBL31472402 0.65 ALDH1A1 (0.48) CA2CA1CYP1A2MAPT
Hydrochloric Acid SCHEMBL6049195 0.64 SLC6A4 (0.45) SLC6A4MAPTSLC6A3SLC6A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1184372-B1 Phenoxyphenylheterocycle derivatives as selective serotonin reuptake inhibitors (SSRIs) PFIZER LTD (GB) 2006-04-26 — — EP disclosed
US-6630504-B2 Activity as selective serotonin re- uptake inhibitors (SSRIs); for therapy and prophylaxis of depression, attention deficit hyperactivity disorder, obsessive-compulsive disorder, post-traumatic stress disorder, sexual dysfunction PFIZER INC. 2003-10-07 — — US disclosed
US-20020183303-A1 Phenoxyphenylheterocyclyl derivatives as SSRIs PFIZER INC. 2002-12-05 — — US disclosed
EP-1184372-A1 Phenoxyphenylheterocycle derivatives as selective serotonin reuptake inhibitors (SSRIs) Pfizer Limited (GB) 2002-03-06 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020183303-A1 Phenoxyphenylheterocyclyl derivatives as SSRIs CRHR1, NR3C1, HTR6 SLC6A4 67/4885CA2 980/4885CA1 798/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback